Sartippour et al. 38revealed that an oral administration of pomegranate extract standardized to ellagitannin content to severe combined immunodeficient mice can decrease prostate cancer xenograft size, tumor vessel density, VEGF peptide levels, and hypoxia-inducible factor 1α expression. Here, VEGFA is linked to neoplasm.